Skip to main content

Table 3 HILPs (%) collected according to stage disease

From: Toxicity and morbility after isolated lower limb perfusion in 242 chemo-hyperthermal treatments for cutaneous melanoma: The experience of the Tuscan Reference Centre

HILP Group Stage
  I II III IV
G-A (n = 60) 48.4 8.3 43.3 -
G-B (n = 74) 78.3 1.3 20.4 -
G-C (n = 108) 0.9 2.7 92.7 3.7